Bicycle Therapeutics PLC banner

Bicycle Therapeutics PLC
F:50BA

Watchlist Manager
Bicycle Therapeutics PLC Logo
Bicycle Therapeutics PLC
F:50BA
Watchlist
Price: 3.34 EUR -1.76%
Market Cap: €229.6m

Wall St Price Targets

50BA Price Targets Summary
Bicycle Therapeutics PLC

Wall Street analysts forecast 50BA stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for 50BA is 9.16 EUR with a low forecast of 4.37 EUR and a high forecast of 12.72 EUR.

Lowest Forecast
Price Target
4.37 EUR
31% Upside
Average Forecast
Price Target
9.16 EUR
174% Upside
Highest Forecast
Price Target
12.72 EUR
281% Upside
Bicycle Therapeutics PLC Competitors:
Price Targets
ULTA
Ulta Beauty Inc
24% Upside

Revenue
Forecast

56% / Year
Past Growth
30% / Year
Estimated Growth
Estimates Accuracy
-7%
Average Miss
56% / Year
Past Growth
30% / Year
Estimated Growth
Estimates Accuracy
-7%
Average Miss

Over the last 8 years, the compound annual growth rate for Revenue has been 56%. The projected CAGR for the next 8 years is 30%.

Gross Profit
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-1%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Pre-Tax Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-4%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-4%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is 50BA's stock price target?
Price Target
9.16 EUR

According to Wall Street analysts, the average 1-year price target for 50BA is 9.16 EUR with a low forecast of 4.37 EUR and a high forecast of 12.72 EUR.

What is the Revenue forecast for Bicycle Therapeutics PLC?
Projected CAGR
30%

Over the last 8 years, the compound annual growth rate for Revenue has been 56%. The projected CAGR for the next 8 years is 30%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett